ResearcherAalborg University HospitalActive in the last 2 years
Benjamin Emil Stubbe
Matched on ORCID iD 0000-0002-2727-5915; OpenAlex author ID A5077266390. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2021: 2 papers · 2022: none · 2023: 2 papers · 2024: none · 2025: 1 paper
Papers 5
- Promoter hypermethylation of SFRP1 is an allele fraction-dependent prognostic biomarker in metastatic pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fonc.2025.1568386↗
- Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with stage III or IV pancreatic ductal adenocar… Co-author DOI 10.1016/j.pan.2023.05.003↗
- Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with localized pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fonc.2023.1211292↗
- Cell-free DNA promoter hypermethylation as a diagnostic marker for pancreatic ductal adenocarcinoma - An external validation study. First author DOI 10.1016/j.pan.2021.05.003↗
- Validation of SFRP1 Promoter Hypermethylation in Plasma as a Prognostic Marker for Survival and Gemcitabine Effectiveness in Patients with Stage IV Pancreatic … Co-author DOI 10.3390/cancers13225717↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Stine Dam Henriksen · 5 shared papers, 2021–2025 · strength 0.81
- Paper Promoter hypermethylation of SFRP1 is an allele fraction-dependent prognostic biomarker in metastatic pancreatic ductal… DOI 10.3389/fonc.2025.1568386↗
- Paper Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with st… DOI 10.1016/j.pan.2023.05.003↗
- Paper Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with lo… DOI 10.3389/fonc.2023.1211292↗
- Ole Thorlacius‐Ussing · 5 shared papers, 2021–2025 · strength 0.81
- Paper Promoter hypermethylation of SFRP1 is an allele fraction-dependent prognostic biomarker in metastatic pancreatic ductal… DOI 10.3389/fonc.2025.1568386↗
- Paper Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with st… DOI 10.1016/j.pan.2023.05.003↗
- Paper Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with lo… DOI 10.3389/fonc.2023.1211292↗
- Julia Sidenius Johansen · 4 shared papers, 2021–2025 · strength 0.67
- Paper Promoter hypermethylation of SFRP1 is an allele fraction-dependent prognostic biomarker in metastatic pancreatic ductal… DOI 10.3389/fonc.2025.1568386↗
- Paper Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with st… DOI 10.1016/j.pan.2023.05.003↗
- Paper Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with lo… DOI 10.3389/fonc.2023.1211292↗
- Carsten Palnæs Hansen · 4 shared papers, 2021–2025 · strength 0.67
- Paper Promoter hypermethylation of SFRP1 is an allele fraction-dependent prognostic biomarker in metastatic pancreatic ductal… DOI 10.3389/fonc.2025.1568386↗
- Paper Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with st… DOI 10.1016/j.pan.2023.05.003↗
- Paper Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with lo… DOI 10.3389/fonc.2023.1211292↗
- Astrid Zedlitz Johansen · 2 shared papers, 2023–2025 · strength 0.36
- Paper Promoter hypermethylation of SFRP1 is an allele fraction-dependent prognostic biomarker in metastatic pancreatic ductal… DOI 10.3389/fonc.2025.1568386↗
- Paper Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with lo… DOI 10.3389/fonc.2023.1211292↗
- Lars Henrik Jensen · 1 shared paper, 2025 · strength 0.19
- Louise S. Rasmussen · 1 shared paper, 2025 · strength 0.19
- Per Pfeiffer · 1 shared paper, 2025 · strength 0.19
- Inna Markovna Chen · 1 shared paper, 2025 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.